Achilles Therapeutics (ACHL) Short Interest Ratio & Short Volume → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free ACHL Stock Alerts $0.95 +0.03 (+3.27%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Achilles Therapeutics Short Interest DataCurrent Short Volume24,000 sharesPrevious Short Volume37,800 sharesChange Vs. Previous Month-36.51%Dollar Volume Sold Short$18,000.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 30, 2024Outstanding Shares39,880,000 sharesFloat Size38,690,000 sharesShort Percent of Float0.06%Today's Trading Volume117,878 sharesAverage Trading Volume188,253 sharesToday's Volume Vs. Average63% Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatACHL Short Interest Over TimeACHL Days to Cover Over TimeACHL Percentage of Float Shorted Over Time Ad InvestorPlaceHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs Achilles Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202424,000 shares $18,000.00 -36.5%0.1%0 $0.75 4/15/202437,800 shares $31,374.00 -49.5%0.1%0 $0.83 3/31/202474,800 shares $93,500.00 +8.6%0.2%0.1 $1.25 3/15/202468,900 shares $75,790.00 -55.2%0.2%0.1 $1.10 2/29/2024153,700 shares $202,884.00 +340.4%0.4%0.2 $1.32 2/15/202434,900 shares $33,497.02 +245.5%0.1%0.1 $0.96[URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond 1/31/202410,100 shares $9,393.00 -79.5%0.0%0 $0.93 1/15/202449,200 shares $43,591.20 +131.0%0.1%0.3 $0.89 12/31/202321,300 shares $18,935.70 -29.2%0.1%0.2 $0.89 12/15/202330,100 shares $26,187.00 +16.2%0.1%0.3 $0.87 11/30/202325,900 shares $21,395.99 -44.7%0.1%0.4 $0.83 11/15/202346,800 shares $37,486.80 +22.2%0.1%0.9 $0.80 10/31/202338,300 shares $32,938.00 +3.5%0.1%0.7 $0.86 10/15/202337,000 shares $33,448.00 -21.9%0.1%0.6 $0.90 9/30/202347,400 shares $43,129.26 +4.4%0.1%0.6 $0.91 9/15/202345,400 shares $40,360.60 +20.4%0.1%0.5 $0.89 8/31/202337,700 shares $34,325.85 -11.1%0.1%0.4 $0.91 8/15/202342,400 shares $41,128.00 -27.8%0.1%0.4 $0.97 7/31/202358,700 shares $59,874.00 +36.5%0.2%0.6 $1.02 7/15/202343,000 shares $42,570.00 +50.9%0.1%0.3 $0.99 6/30/202328,500 shares $26,938.20 -0.4%0.1%0.2 $0.95 6/15/202328,600 shares $28,030.86 +50.5%0.1%0.2 $0.98 5/31/202319,000 shares $19,000.00 +28.4%0.1%0.1 $1.00 5/15/202314,800 shares $14,356.00 +114.5%0.0%0.1 $0.97 4/30/20236,900 shares $5,727.00 -57.9%0.0%0 $0.83 4/15/202316,400 shares $14,596.00 +26.2%0.0%0.1 $0.89 3/31/202313,000 shares $12,447.50 +106.4%0.0%0.1 $0.96 3/15/20236,300 shares $5,827.50 -33.7%0.0%0 $0.93 2/28/20239,500 shares $10,450.00 -78.0%0.0%0 $1.10 2/15/202343,200 shares $48,384.00 +163.4%0.1%0.1 $1.12 1/31/202316,400 shares $20,336.00 -49.2%0.0%0 $1.24 1/15/202332,300 shares $38,114.00 -59.1%0.1%0.1 $1.18 12/30/202279,000 shares $71,100.00 -30.9%0.2%0.2 $0.90 12/15/2022114,300 shares $125,730.00 -9.3%0.3%0.7 $1.10 11/30/2022126,000 shares $254,520.00 +2.1%0.3%2.4 $2.02 11/15/2022123,400 shares $213,482.00 +72.4%0.3%2.5 $1.73 10/31/202271,600 shares $138,188.00 +37.4%0.2%2.7 $1.93 10/15/202252,100 shares $109,410.00 -1.1%0.1%1.9 $2.10 9/30/202252,700 shares $119,102.00 +6.3%0.1%1.6 $2.26 9/15/202249,600 shares $144,832.00 +4.2%0.1%1.4 $2.92The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. ACHL Short Interest - Frequently Asked Questions What is Achilles Therapeutics' current short interest? Short interest is the volume of Achilles Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 24,000 shares of ACHL short. 0.06% of Achilles Therapeutics' shares are currently sold short. Learn More on Achilles Therapeutics' current short interest. What is a good short interest percentage for Achilles Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.06% of Achilles Therapeutics' floating shares are currently sold short. Is Achilles Therapeutics' short interest increasing or decreasing? Achilles Therapeutics saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 24,000 shares, a drop of 36.5% from the previous total of 37,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Achilles Therapeutics' float size? Achilles Therapeutics currently has issued a total of 39,880,000 shares. Some of Achilles Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Achilles Therapeutics currently has a public float of 38,690,000 shares. How does Achilles Therapeutics' short interest compare to its competitors? 0.06% of Achilles Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Achilles Therapeutics: SAB Biotherapeutics, Inc. (0.30%), Pluri Inc. (0.97%), Estrella Immunopharma, Inc. (0.12%), MiNK Therapeutics, Inc. (0.88%), Brainstorm Cell Therapeutics Inc. (3.00%), Quince Therapeutics, Inc. (6.58%), Surrozen, Inc. (2.15%), Cyclo Therapeutics, Inc. (0.35%), OKYO Pharma Limited (0.43%), Dyadic International, Inc. (0.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Achilles Therapeutics stock? Short selling ACHL is an investing strategy that aims to generate trading profit from Achilles Therapeutics as its price is falling. ACHL shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Achilles Therapeutics? A short squeeze for Achilles Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACHL, which in turn drives the price of the stock up even further. How often is Achilles Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACHL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SABS Short Squeeze PLUR Short Squeeze ESLA Short Squeeze INKT Short Squeeze BCLI Short Squeeze QNCX Short Squeeze SRZN Short Squeeze CYTH Short Squeeze OKYO Short Squeeze DYAI Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACHL) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits